TCW Group trims Pfizer holding after selling 43,819 shares
TCW Group reduced its Pfizer stake by selling 43,819 shares during the quarter, leaving it with 2,669,765 shares. HFM Investment Advisors bought more shares, while Abound Financial added a new position worth about $31,000. Pfizer reported Q2 EPS of $0.77, above consensus, but dividend payout ratio stands at 226.32%, and several analysts cut price targets to around $28.